LINDA PHAM: Open Payments
NPI 1871064170 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 27 payments from 13 companies in 2025. Trend: 2023 $65 · 2024 $190 · 2025 $669
Food & beverage: $655Education: $14
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $105 |
| Lilly USA, LLC | 3 | $87 |
| Amgen Inc. | 3 | $78 |
| Galderma Laboratories, L.P. | 4 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $66 |
| UCB, Inc. | 2 | $55 |
| Incyte Corporation | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $24 |
Products named: TREMFYA, TALTZ, OTEZLA, NEMLUVIO, Winlevi, Bimzelx, OPZELURA, COSENTYX.
Industry payments across MA — which companies pay providers there.
